OOIR: Observatory of International Research

Papers

(The median citation count of Therapeutic Advances in Endocrinology and Metabolism is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
GLP-1 receptor agonists: an updated review of head-to-head clinical studies	116
Should metformin remain the first-line therapy for treatment of type 2 diabetes?	55
Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis	33
MAFLD: a multisystem disease	31
The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence	27
Role of inflammation in diabetic cardiomyopathy	25
Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use	23
Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection	23
Insulin resistance in transgender individuals correlates with android fat mass	20
Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data	19
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?	18
Advancements in the treatment of differentiated thyroid cancer	17
The importance of physical activity in management of type 2 diabetes and COVID-19	16
Clinical approaches to treat impaired awareness of hypoglycaemia	16
Diabetes clinic reinvented: will technology change the future of diabetes care?	16
NAFLD in type 1 diabetes: overrated or underappreciated?	15
Current updates on protein as biomarkers for diabetic kidney disease: a systematic review	13
Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis	13
Therapeutics for type-2 diabetes mellitus: a glance at the recent inclusions and novel agents under development for use in clinical practice	12
Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future	11
Low complication rates of testosterone and estradiol implants for androgen and estrogen replacement therapy in over 1 million procedures	11
Body composition and cardiometabolic health of pediatric patients with X-linked hypophosphatemia (XLH) under burosumab therapy	11
Endotrophin as a novel marker in PCOS and its relation with other adipokines and metabolic parameters: a pilot study	11
Alteration of serum neuregulin 4 and neuregulin 1 in gestational diabetes mellitus	10
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity	10

Recent advancement in the treatment of boys and adolescents with hypogonadism	9
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease	9
Calcitonin: current concepts and differential diagnosis	9
The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice	9
Digital health and diabetes: experience from India	9
Prediction of cardiac autonomic neuropathy using a machine learning model in patients with diabetes	8
Bone health in transgender people: a narrative review	8
Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes	8
Primary aldosteronism subtyping in the setting of partially successful adrenal vein sampling	8
The effect of specific binding proteins on immunoassay measurements of total and free thyroid hormones and cortisol	8
Decreased serum C1Q/TNF-related protein 4 concentrations are associated with type 2 diabetes mellitus	7
Update on genetics and epigenetics in metabolic associated fatty liver disease	7
Sex and ethnic differences in the cardiovascular complications of type 2 diabetes	7
Potential immunological effects of gender-affirming hormone therapy in transgender people – an unexplored area of research	7
Therapeutic approaches for non-alcoholic steatohepatitis	7
Should denosumab treatment for osteoporosis be continued indefinitely?	6
Screening for MAFLD: who, when and how?	6
Impact of TPOAb-negative maternal subclinical hypothyroidism in early pregnancy on adverse pregnancy outcomes	6
Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials	6
Pharmacological management of severe Cushing’s syndrome: the role of etomidate	6
Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic kidney disease	6
Relationship between total testosterone, sex hormone–binding globulin levels and the severity of non-alcoholic fatty liver disease in males: a meta-analysis	6
The management of acute and chronic hyponatraemia	6
Menopause, androgens, and cardiovascular ageing: a narrative review	6
Cardiovascular and systemic determinants of exercise capacity in people with type 2 diabetes mellitus	6
Diabetes mellitus in dialysis and renal transplantation	5
Non-pharmacological management options for MAFLD: a practical guide	5
Factors influencing height gain in children born small for gestational age treated with recombinant growth hormone: what extent is puberty involved?	5
MAFLD: what 2 years of the redefinition of fatty liver disease has taught us	5
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study	5
Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome	5
The relation of anatomical distribution of symptomatic peripheral arterial disease (PAD) with HbA1c level in patients with type 2 diabetes mellitus	5
Novel therapeutic targets and agents for pediatric dyslipidemia	4
Increased serum calcium levels are associated with carotid atherosclerotic plaque in normocalcaemic individuals with type 2 diabetes	4
Timing of osteoporosis therapies following fracture: the current status	4
Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China	4
Normocalcaemic primary hyperparathyroidism: what is the role of parathyroid surgery?	4
Current concept of stress fractures with an additional category of atypical fractures: a perspective review with representative images	4
Anti-obesity medication prescriptions by race/ethnicity and use of an interpreter in a pediatric weight management clinic	4
Relationship between sleep pattern and bone mineral density in patients with osteoporotic fracture	4
Designing an integrated, nurse-driven and home-based digital intervention to improve insulin management in under-resourced settings	4
Emerging pharmacological treatment options for MAFLD	4
Gender-affirming endocrine care for youth with a nonbinary gender identity	3
Should we undertake surveillance for HCC in patients with MAFLD?	3
Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective	3
Metabolic benefits of changing sedentary lifestyles in nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials	3
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers	3
Evolution of anaplastic thyroid cancer management: perspectives in the era of precision oncology	3
Exploring the weight bias of professionals working in the field of obesity with a mobile IAT: a pilot study	3
Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges	3

Feasibility and acceptance of a virtual multidisciplinary care programme for patients with type 2 diabetes during the COVID-19 pandemic	3
Long-term follow up of carbohydrate metabolism and adverse events after termination of Omnitrope® treatment in children born small for gestational age	3
Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome	3
RANKL inhibition: a new target of treating diabetes mellitus?	3
Testosterone concentrations and prescription patterns of 1% testosterone gel in transgender and gender diverse individuals	3
Pheochromocytoma: a changing perspective and current concepts	3
The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves’ disease	3
Association of continuous glucose monitoring-derived time in range with major amputation risk in diabetic foot osteomyelitis patients undergoing amputation	3